Diets containing soybean protein generally induce low levels of serum cholesterol in experimental animals, when compared with diets containing casein. The hypocholesterolemia in animals fed soybean protein is associated with increased rates of fecal excretion of bile acids and neutral steroids, low liver cholesterol concentra tions, increased numbers of hepatic apo B/E receptors, increased rates of hepatic cholesterol synthesis, increased rates of bile acid synthesis and decreased rates of lipoprotein cholesterol output by the liver. In this communication the development of the hypocholesterolemia induced by soybean protein is described. The various mechanisms that have been proposed to explain the hypocholester olemic effect of soybean protein are scrutinized, compared and contrasted.
The amount and type of fat in the protein preparations could be important. The amount of fat in the cholesterol-free diet of rats must be as little as 1% (w/w) in order to demonstrate a hypocho lesterolemic effect of soybean protein versus casein (2) . It could be suggested (3) that this actually represents a fat effect. Since soybean protein isolate contains up to 5% of fat, and casein about 1%, animals fed the former protein received more fat , this soybean fat being rich in polyunsaturated fatty acids. Perhaps, the animals fed the low-fat casein diet had a marginal deficiency of polyunsaturated fatty acids, which amplified the protein effect on serum cholesterol. This would explain why the addition of extra corn oil to the diets counteracted the differential cholesterolemic response to feeding soybean protein and casein (2) . After feeding rabbits on semipurified diets containing either casein or soybean protein, but carefully balanced for residual fat and cholesterol in the protein preparations, the differential cholesterolemic effect of the proteins became very small (4). However, when cholesterol was added to the diets to a final concentration of 0.15%, a marked hypocholesterolemic effect of soybean protein could be demonstrated (4) . This indicates that the protein component of the protein preparations specifically influences serum cholester ol concentrations.
Fecal excretion of bile acids and neutral steroids
In rabbits, the fecal excretion of cholesterol and its bacterial metabolites (5, 6) and of bile acids (6 , 7) is decreased almost immediately after soybean protein is replaced by casein, and before the concentration of serum cholesterol is increased . This suggests that effects of the dietary proteins on the enterohepatic circulation of bile acids and cholesterol is at least one of the primary features of protein-induced changes in serum cholesterol con centrations. Dietary proteins do not influence the biliary efflux of bile acids and neutral ster oids (8, 9) . This would imply that soybean protein versus casein affects intestinal absorption of cholesterol and bile acids.
There is direct evidence that soybean protein impairs cholesterol absorption (10) (11) (12) . There is only indirect evidence that soybean protein inhibits the absorption of bile acids: as mentioned above , in animals fed soybean protein, bile acid excretion in feces is increased. Furthermore, in pigs fitted with re-entrant cannulas at the end of the ileum and in the cecum, the ileal output of bile acids is higher and the uptake of bile acids by cecum and/or colon is lower in animals fed soybean protein compared with their counterparts fed casein (13) . Thus , it would appear that soybean protein inhibits the (re-)absorption of cholesterol and bile acids, which in turn leads to increased excretion of neutral steroids and bile acids in feces. Interaction between dietary soybean protein and intestinal steroids The reasoning above implies that the first step in cholesterol lowering induced by soybean protein versus casein involves inhibition of cholesterol and bile acid absorption. Thus, the primary effect of soybean protein is at the level of the intestine. However, there is no direct evidence that soybean protein depresses bile acid absorption. It could be argued that the primary effect of soybean protein is stimulation of hepatic bile acid synthesis which then leads to increased fecal excretion of bile acids and decreased liver cholesterol concentrations. However, it is difficult to see how increased biliary output of bile acids would lead to the observed inhibition of cholesterol absorption in animals fed soybean protein.
Saeki et al. (19) have shown that neither jejunectomy nor ileectomy in rats affects the response of serum cholesterol to soybean protein versus casein. This would exclude that interactions between dietary proteins and intestinal steroids are responsible for their cholesterolemic effects. Two comments should be made here. First, in the studies of Saeki et al. (19) , only 1% of corn oil as the sole source of fat was added to the base diet. Using such diets containing either 20% of soybean protein or casein entails a considerable risk of the fat type in the protein preparations determining the cholester olemic response to the diets. This problem has been addressed above. Secondly, the studies with jejunectomized or ileectomized rats do not exclude interactions between dietary proteins and bile acids at the level of the large intestine. Studies with cannulated pigs have shown that soybean protein depresses bile acid absorption in cecum and/or colon (13 fact that soybean protein is less digestible than casein and purports that undigested protein binds bile acids and neutral steroids and thereby reduces steroid (re-)absorption. This concept is supported by in vitro experiments (20) , and by the observation that mice fed soybean protein had increased amounts of nitrogen and bile acids in their intestine compared with animals fed casein (21) . Furthermore, Sugano et al. (22) have isolated a high-molecular weight fraction from soybean protein that stimulates fecal bile acid and neutral steroid excretion and is more hypocholesterolemic than equal amounts of intact soybean protein when fed to rats. There is indirect evidence that the high-molecular weight fraction of soybean protein, which is a hydrophobic peptide, may bind bile acids in the intestine (23) . However , the high molecular weight fraction of soybean protein is rich in saponins (22) which may have contributed to the cholesterol lowering activity of this fraction. The digestibility theory is not supported by the observation that formaldehyde treatment of casein, which lowers its digestibility , does not lower serum cholesterol concentrations in cholesterol-fed rats (24) and rabbits (25) . The second concept to explain inhibition of intestinal steroid absorption in animals fed soybean protein versus casein, relates to the differential phosphorylation state of the two proteins (26) . Casein, when compared with soybean protein , is a highly phosphorylated protein as about 40% of the serine residues in casein are esterified with phosphate. The phosphorylation concept can be described as follows. Dietary casein and phosphopeptides derived from it remove calcium from the calcium phosphate sediment in the intestine and thereby dissolves the sediment and solubilizes phosphate. This reduces the number of binding sites on the sediment for bile acids and increases the concentration of free bile acids. As a result , bile acid absorption increases. Put in another way, in animals fed soybean protein, more intestinal bile acids are bound to the calcium phosphate sediment, and will eventually reach the feces. The phosphorylation concept is supported both by in vitro and in vivo experiments. In vitro, casein, when compared to soybean protein or dephosphorylated casein, prevents the binding of glycine-conjugated bile acids to the calcium phosphate sediment (26) . In contrast to glycine-conjugated bile acids, taurine-con jugated bile acids do not bind to the calcium phosphate sediment (27) . As would be anticipated, dietary casein stimulated the absorption of phos phate (28) . Moreover, the hypercholesterolemia in rabbits induced by feeding casein was partly counteracted by addition of calcium carbonate to the diet (28) . Addition of calcium carbonate to the diet will prevent dissolution of the calcium phosphate sediment as induced by phosphopeptides.
The phosphorylation concept would explain why cholesterol absorption is decreased in animals fed soybean protein, and it also explains species differences in the sensitivity to dietary proteins . As to the former, it is reasonable to assume that changes in the efficiency of absorption of cholesterol and bile acids go hand in hand: the two steroids are absorbed in the form of mixed biliary micelles . As to species-differences, rabbits are more sensitive to the type of dietary protein than rats . Rabbits, when compared with rats, have low intestinal phosphatase activity, and their bile acids are almost exclusively conjugated with glycine (29) . Thus, in rabbits , but not in rats, there is substantial bile acid binding to the intestinal calcium phosphate sediment which can be diminished by the feeding of casein .
The weak point of the phosphorylation concept is that it may be restricted to the comparison of casein and soybean protein, and may not extend to other animal proteins that are not highly phosphor ylated but do increase serum cholesterol concentra tions. Furthermore, it is difficult to see that casein and its phosphopeptides could influence bile acid absorption in the large intestine since proteins are completely digested at this stage. Dietary soybean protein versus casein may inhibit bile acid absorption in cecum and/or colon (13) .
Mechanisms with primary features at the postabsorp tive level Several mechanisms at the postabsorptive level have been proposed to explain the hypocholester olemic effect of soybean protein . It has been suggested that oligopeptides derived from soybean protein and absorbed intactly, might have cholester olemic effects (30) . However, at present there is no metabolic basis for this suggestion .
Dietary soybean protein, when compared with casein, has been shown to lower the insulin: gluca gon ratio in rats (31) and swine (13) , but the opposite was seen in gerbils (32) . So far there is no coherent metabolic basis for changes in the insulin: glucagon
ratio being a causative factor in protein-induced cholesterolemia.
Single amino acids (33, 34) , including the lysine: arginine ratio (35, 36) in dietary proteins have been proposed to be responsible for the effects of the intact proteins. The involvement of single amino acids is based on studies showing that the addition of amino acids to the diets of experimental animals perturbs serum cholesterol concentrations (33) (34) (35) . However, there is no metabolic basis for the action of amino acids. Furthermore, it is questionable whether the experimental feeding of amino acids can provide information about the mechanism of action of intact proteins. Digestion and absorption of intact proteins differs from that of single amino acids. Nagata et al. (11) have shown that the feeding of amino acid mixtures simulating soybean protein or casein produced serum cholesterol concentrations in rats that were identical to those seen after feeding the intact proteins. However, the amino acid mixtures and intact proteins had different effects on other aspects of cholesterol metabolism, such as fecal steroid excretion (11). 
